Secondary analysis of two RCTs in heart transplant recipients (SCHEDULE, n=83; NOCTET, n=75): replacing calcineurin inhibitors with everolimus, or reducing calcineurin inhibitor dose with everolimus, did not change left ventricular mass versus standard calcineurin inhibitors.
Secondary analysisn = 158
Murbraech et al. Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients-Results From Two Randomized Controlled Trials